When Better Is Not Enough: How Incentives and System Constraints Shape Healthcare Adoption

There is a persistent and dangerous assumption in the healthcare industry: if the science is better, adoption will follow. It sounds rational. In practice, it is one of the most costly misconceptions a Medical Affairs team can hold. 

I have seen this dynamic from both sides — first as an ophthalmologist in clinical practice for nearly two decades, and now as a Medical Affairs manager operating at the intersection of evidence generation and real-world strategy. A product can demonstrate superior efficacy, a favorable safety profile, and reduced downstream interventions, yet still face limited adoption. The problem, in most cases, is not the molecule. It is the system into which that molecule is introduced. 

The Fallacy of Self-Evident Technology 

Clinical trials operate under conditions of deliberate control. They isolate variables, minimize noise, and produce an idealized measurement of efficacy. Healthcare systems, however, function as complex ecosystems shaped by institutional protocols, entrenched prescribing behaviors, operational constraints, and economic structures.

When a new product enters this environment, it is not evaluated solely on its clinical merit. It is evaluated on system fit.  

Does it require changes in workflow? 

Does it introduce logistical complexity? 

Does it align with reimbursement structures?  

Each of these questions represents a potential barrier — independent of the robustness of clinical data.  

Healthcare systems do not adopt what performs best in isolation. They adopt what integrates best into reality. This dynamic reflects a process of system selection, in which adoption is determined by compatibility across clinical, operational, and economic dimensions.

System selection is not random — it is structurally driven by incentive alignment and constrained by operational friction. 

Friction Is Visible. Incentives Are Decisive. 

Operational friction is often the most visible barrier to adoption. However, it is frequently a downstream manifestation of a deeper and more powerful force: incentive structure.  

Innovation fails when it cannot answer a simple, often unspoken question from each stakeholder: “How does this improve my specific metric of success?”  

Consider three common scenarios:  

The provider’s paradox. A hospital operating under fee-for-service reimbursement may have limited incentive to adopt a therapy that reduces length of stay. What is clinically efficient can be financially counterintuitive unless bed capacity is constrained.  

The payer’s time horizon. A therapy that prevents long-term complications may generate substantial downstream savings. Yet, if the payer operates under annual budget constraints or high patient turnover, those benefits may not translate into immediate decision-making value.  

The prescriber’s cognitive load. Even clinically superior solutions face resistance if they require significant changes in prescribing habits, workflow disruption, or increased administrative burden without a clear and immediate benefit to the physician.  

In healthcare systems, incentives do not operate in isolation — they permeate and ultimately shape everything else. 

Three Vectors That Determine Adoption 

Healthcare adoption can be understood as the intersection of three essential vectors:  

Evidence. The foundation. Without robust clinical data, no meaningful conversation begins.

Operationalization. The ability to implement a solution within the constraints of real-world care delivery.  

Aligned incentives. The structural driver that determines whether evidence and implementation will translate into action.  

These elements are often treated as independent. In reality, they are deeply interconnected.  

Evidence can be published. Implementation can be trained. But misaligned incentives will systematically undermine both.  

A product with strong clinical performance and a viable implementation pathway may still fail if physicians, hospital administrators, and payers are responding to conflicting signals. 

From Molecule to Solution: A System-Level Shift 

The implication is clear: success in healthcare is no longer defined by delivering a superior molecule alone, but by designing solutions that align with the system in which they operate.  

This requires a shift from product-centric thinking to system-aware strategy.  

It begins with a deep understanding of the patient journey and the operational bottlenecks that define care delivery. When these constraints are understood, evidence can be positioned not as an abstract demonstration of superiority, but as a direct solution to a recognized problem.  

If a hospital is constrained by bed turnover, value must be framed in terms of length of stay. 

If workflow variability is a bottleneck, consistency becomes a key driver.  

Adoption in healthcare is not a function of clinical superiority alone, but of systemic compatibility.  Value is not intrinsic to the product. It is realized through its interaction with the system. 

The Strategic Role of Medical Affairs

In this environment, Medical Affairs must evolve beyond its traditional role.  

Scientific rigor remains essential, but it is no longer sufficient. The function must act as a strategic integrator—bridging clinical evidence, operational realities, and incentive structures. 

This means understanding stakeholder-specific decision drivers, translating evidence into context-specific value, and aligning scientific communication with system-level constraints. 

The role is no longer limited to explaining data. It is about enabling adoption. 

Closing Perspective 

The healthcare industry will continue to generate extraordinary technologies. Some will transform care. Many will fail to reach their potential— not because the science failed, but because the system was ignored.  

Understanding how healthcare systems function—their incentives, constraints, and decision dynamics—is not peripheral knowledge. It is central to impact.  

In the end, success in healthcare is not determined by what performs best in isolation, but by what aligns best with reality.  

Better is necessary. It is not sufficient.